2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
8
Completed
8
Not yet recruiting
3
Unknown
2
Active not recruiting
2
Withdrawn
1
Terminated
1
Suspended
1
Enrolling by invitation
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
47
Breast Neoplasms
46
Colorectal Neoplasms
28
Prostatic Neoplasms
26
Carcinoma, Non-Small-Cell Lung
21
Leukemia, Myeloid, Acute
19
Glioblastoma
19
Pancreatic Neoplasms
17
Melanoma
17
Lung Neoplasms
17
Neoplasm Metastasis
16
Glioma
14
Stomach Neoplasms
13
Carcinoma, Hepatocellular
13
Brain Neoplasms
13
Ovarian Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Myelodysplastic Syndromes
11
Triple Negative Breast Neoplasms
10
Multiple Myeloma
10
Head and Neck Neoplasms
10
Carcinoma, Renal Cell
10
Lymphoma
9
Uterine Cervical Neoplasms
7
Rectal Neoplasms
7
Hematologic Neoplasms
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Sarcoma
6
Leukemia
6
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Cytokine Release Syndrome
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled